(In the Media) ‘Regenerative Medicine: Promoting prompt review in Japan’ (Nippon Keizai Shimbun, December 5, 2014) (In Japanese)
date : 12/5/2014
HGPI’s
Toshio Miyata provides his views on the Act Concerning Safety Assurance
on Regenerative Medicine, which became effective on November 26, 2014.
The aim of this act is to spread regenerative medicine promptly and
safely.
Top Research & Recommendations Posts
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022）
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
![[Registration Open] Online Seminar “Implementing Chronic Kidney Disease (CKD) Measures into Society: Towards a Data-Driven Health System” (April 21, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20260421_CKDonlineseminar-.png)
